Table 5 Included randomised controlled trials on primary liver cancer Study ID population Intervention Key outcomes Method Comparator Study type Location Shibata et al 2002. 72 patients with 94 RFA No statistically significant differences between the treatments for therapeutic percutaneous HCC nodules effect, major complications or rates of residual foci of untreated disease. The RCT number of treatment sessions per nodule was significantly lower for the RFA group. HCC = hepatocellular carcinoma; RCT = randomised controlled trial; RF A= radiofrequency ablation; Table 6 Included randomised controlled trial on secondary liver cancer Study ID population Intervention Key outcomes Method Comparator Study type Location Shibata et al. 2000 30 patients with multiple resection No statistically significant difference in 1-, 2- and 3-year survival rates between laparoscopic metastatic CRC treatments. Statistically significant lower level of blood loss in MTA treatment. RCT CRC = colorectal cancer; MTA = microwave tissue ablation; RCT = randomised controlled trial
Table 5 Included randomised controlled trials on primary liver cancer Study ID Study type Location population Intervention Comparator Key outcomes Method Shibata et al 2002. RCT 72 patients with 94 HCC nodules RFA No statistically significant differences between the treatments for therapeutic effect, major complications or rates of residual foci of untreated disease. The number of treatment sessions per nodule was significantly lower for the RFA group. percutaneous HCC = hepatocellular carcinoma; RCT = randomised controlled trial; RF A= radiofrequency ablation; Table 6 Included randomised controlled trial on secondary liver cancer Study ID Study type Location population Intervention Comparator Key outcomes Method Shibata et al. 2000 RCT 30 patients with multiple metastatic CRC resection No statistically significant difference in 1-, 2- and 3-year survival rates between treatments. Statistically significant lower level of blood loss in MTA treatment. laparoscopic CRC = colorectal cancer; MTA = microwave tissue ablation; RCT = randomised controlled trial